Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00829556 · ClinicalTrials.gov registry record · NA
Efficacy of InteguSeal for Surgical Skin Preparation in Patients Undergoing Total Joint Replacement
A NA study, sponsored by Rothman Institute Orthopaedics.
- Completed
- Registry status
- NA
- Development phase
- 160
- Enrollment target
NCT00829556: Completed NA study, sponsored by Rothman Institute Orthopaedics.
NCT00829556 is a NA study that has completed, run by Rothman Institute Orthopaedics. The registered enrollment target is 160 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00829556, a NA study, has completed, sponsored by Rothman Institute Orthopaedics.
- COMPLETED
- Registry status
- NA
- Development phase
- 160 participants
- Enrollment target
Study Summary
This study is being conducted to investigate the potential benefits of using a special type of fluid that can be applied to the skin (Integuseal) in addition to standard surgical skin preparation in patients undergoing total hip replacement (THA) or total knee replacement (TKA). Integuseal is supposed to lock down the skin bacteria and reduce skin infection and other problems. This study will investigate whether Integuseal is effective in reducing persistent wound drainage when used in addition to standard surgical skin preparation for total hip arthroplasty (THA) or total knee replacement (TKA).
Interventions
- DEVICE Integuseal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2008-04 |
| Est. Completion | 2009-09 |
| Phase | NA |
What the finished NCT00829556 record still lists
NCT00829556 is an interventional study that assigns participants to a tested intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 1 intervention - of which Integuseal is the first listed.
NCT00829556 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00829556 about?
NCT00829556 is a clinical study titled "Efficacy of InteguSeal for Surgical Skin Preparation in Patients Undergoing Total Joint Replacement". This study is being conducted to investigate the potential benefits of using a special type of fluid that can be applied to the skin (Integuseal) in addition to standard surgical skin preparation in patients undergoing total hip replacement (THA) or total knee replacement (TKA). Integuseal is suppos...
What is the current status of trial NCT00829556?
This trial is currently completed. It is a NA study. The enrollment target is 160 participants. The study started on 2008-04. Estimated completion is 2009-09.
What interventions are being tested in trial NCT00829556?
The interventions under investigation include: Integuseal (DEVICE).
Who is sponsoring clinical trial NCT00829556?
This trial is sponsored by Rothman Institute Orthopaedics, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00829556's enrollment target sits among peer trials
160 628th of 2000 higher than 1,347 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00501826 · 160 participants · Phase 2
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- NCT00932139 · 160 participants · NA
Effect of Electro-Acupuncture on Blood Pressure
- NCT00992901 · 160 participants · Early Phase 1
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- NCT01515527 · 160 participants · Phase 2
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia